During viral infections, the sites of virus replication represent complex microenvironments whose effects on viral infection remain to be understood. In contrast to cytokines (Stark et al., 1998) , the implication of proteases, which are produced in large amounts by inflammatory cells (Steinhoff et al., 2005) , still remains enigmatic. Extracellular proteases are known to increase infectivity of several viruses through the cleavage of virion proteins necessary to pursue the viral life cycle (Zhirnov et al., 2002) , but the possibility that such a phenomenon could be mediated through cell signalling has never been documented. The aim of our study was to test this hypothesis by using the herpesvirus model of Pseudorabies virus (PRV) (Klupp et al., 2004; Mettenleiter, 2002; Ray & Enquist, 2004) . We report here that trypsin increases viral production by PRV-infected cells through activation of the ERK1/2 pathway.
In order to address the effect of trypsin on PRV replication, PK15 cells were infected (3 h, m.o.i. of 20) and then treated or not with trypsin (Becton Dickinson,~410 BAEE units ml
21
, 50 mM, 5 min). We performed this delayed treatment to exclude the possibility of a direct effect of trypsin on virus particles. The cells were then returned to medium to let the infection proceed for 13 or 24 h. Viral growth was evaluated by titrating the virus in the supernatants using a plaque assay. When exposed to trypsin, PRV-infected cells subsequently produced more infectious virus (Fig. 1a, left panel) , as indicated by the statistical Mann-Whitney test analysis (P<0?05 at t=24 h). Similar results were observed by using sucrose gradient-purified virus (Fig. 1a, right panel) and in Madin-Darby bovine kidney (MDBK; Fig. 1b ) or ST (data not shown) cells. Thus, trypsin triggers an intracellular process leading to increased virus production in PRVinfected cells. To our knowledge, this is the first report demonstrating that proteases can mediate the enhancement of viral production through an effect on the infected cell. Whether this occurs through protease-activated receptors (Ossovskaya & Bunnett, 2004) and whether this is accompanied by an increased synthesis of virus proteins remain to be determined. Activation of the ERK1/2 intracellular signalling pathway is known to be associated with increased viral growth in several models of viral infection (Luo et al., 2002; Pleschka et al., 2001 ) and activation of this pathway has been reported in proteasemediated signalling (Brown et al., 2001; DeFea et al., 2000) . Thus, in order to investigate its possible involvement in the increased virus production induced by trypsin in infected cells, PK15 cells were either mock-or PRV-infected and treated 3 h later with trypsin for 5, 30 or 120 min or left unexposed for the same length of time. Activation of the ERK1/2 pathway was then assessed by Western blot analysis using an anti-phospho-ERK antibody (Cell Signaling Technology). The results (Fig. 2a) showed that, in mockinfected cells, ERK1/2 was phosphorylated after a 5 min exposure to trypsin, whilst after exposure for a longer time (between 30 and 120 min), the phosphorylation dropped below the basal level. These results were consistent with previous reports showing that trypsin treatment transiently activates the ERK1/2 pathway in several cell lines (Brown et al., 2001; DeFea et al., 2000) . In contrast, virus and trypsin triggered a synergistic activation of ERK1/2 that increased over the time course of trypsin exposure in PRVinfected cells. The same results were also observed in MDBK (Fig. 2b , left panel) and RK13 (data not shown) cells and by using purified virus (Fig. 2b , middle panel). However, this was not observed with the heat-inactivated virus (Fig. 2b , right panel), in spite of its capacity to adsorb to the cells (data not shown), suggesting that productive infection is needed for the synergistic activation of the ERK1/2 pathway. Antibodies against ERK1/2 (Cell Signaling Technology) and PRV glycoprotein gE (Eloit et al., 1988) were used as controls. Similar results were also observed by using a lower concentration of trypsin, but only when PK15 cells were maintained in serum-free medium (Fig. 2c) , suggesting that serum trypsin inhibitors block the phenomenon. Thus, PRV infection and subsequent trypsin treatment induce a synergistic activation of ERK1/2. This activation could be either direct or indirect through host factors released by infected cells. It would be interesting to investigate, for example, whether trypsin treatment results in activation of the epidermal growth factor receptor through release of transforming growth factor alpha (Darmoul et al., 2004) . Efficient signalling by Ras, an activator of the ERK pathway, implicates its translocation into lipid rafts (Dykstra et al., 2003; Roy et al., 1999) . As virus may alter raftdependent signalling (Avota et al., 2004; Favoreel et al., 2004; Mañes et al., 2003) , we investigated the potential recruitment of ERK into these fractions. Raft analysis in PK15 cells, done as described previously (Riteau et al., 2003) , showed that fractions 3, 4, 5, 10, 11 and 12 reacted with subunit B of the cholera toxin (Sigma-Aldrich) and anti-ERK1/2, respectively (Fig. 2d) . These fractions were thus subsequently pooled and referred to as raft and soluble fractions, respectively. Rafts were then isolated from PK15 cells that were mock-or PRV-infected and later exposed or not to trypsin. Immunoblotting analysis using the cholera toxin and the anti-gE antibody showed that rafts were located similarly in all of the experiments and that they were selectively enriched in the mature form of the gE protein (Fig. 2e) . Finally, whatever the cell treatment, most of the ERK1/2 proteins were detected in the detergent-soluble fractions (Fig. 2e) , but only trypsin-treated infected cells displayed detectable raft-associated ERK1/2 that, moreover, appeared to be phosphorylated. Therefore, virus and trypsin induce the recruitment of ERK1/2 into rafts. As rafts act as signalling platforms (Dykstra et al., 2003) and are often hijacked by viruses to improve their replication (Mañes et al., 2003) , rafts may be the starting point of the synergistic ERK1/2 activation. We finally tested whether a link could exist between ERK1/2 activation and the increased viral production in PRV-infected cells exposed to trypsin. PRV-infected cells were thus exposed or not to trypsin in the presence of either DMSO or 60 mM of the ERK1/2 signalling-pathway inhibitor U0126 (Promega), which worked efficiently under these conditions (Fig. 3a) . The kinetics of virus growth were established for the four conditions tested by titrating infectious virus in the supernatant by a plaque assay (Fig. 3b) . Trypsin treatment increased virus production by PRV-infected cells, but not in the presence of U0126, indicating that U0126 blocks the increased viral production induced by trypsin. In the absence of trypsin, U0126 also decreased PRV production, suggesting that, even in the absence of trypsin stimulation, ERK1/2 may be beneficial for virus replication. The pool of ERK responsible for this phenomenon could be the basal level of activated ERK observed in PK15 cells. Although we cannot exclude the possibility that the inhibition of PRV might be due to an intrinsic property of U0126, it is noteworthy that lactate dehydrogenase cell-viability assays (CytoTox96; Promega) showed that a 27 h treatment with U0126 had no toxic effect on PK15 cells. Altogether, these results suggest that the synergistic activation of the ERK1/2 signalling pathway observed in PRV-infected cells exposed to trypsin is necessary for increased viral production. Activation of this MAP kinase pathway seems to be specific, as the activation of JNK was not detectable in our experiments (data not shown). It is possible that ERK1/2 activation mediates increased viral production by affording cells an increased survival time, as described previously for several viruses (Luo et al., 2002; Perkins et al., 2003) . Alternatively, ERK1/2 activation increases virus production directly by stimulating virus replication and/or expression of viral genes. Altogether, these studies suggest that proteases may play an important role in modulating virus pathogenesis. or mock infection was done either as described in the text (left) or in FCS-free medium (right). Three hours later, the cells were exposed to 500 nM trypsin for 120 min and analysed as in (a). The numbers at the right of the figure refer to M r in kDa. (d) Detergent-soluble-and -insoluble-domain fractions of uninfected PK15 cells were characterized by sucrose-gradient ultracentrifugation. Fractions 2-12 were analysed by Western blot using the cholera toxin B subunit (GM1) and anti-ERK mAb (ERK). (e) Monolayers of PK15 cells were infected by PRV at an m.o.i. of 20 (+) or mock-infected ("). Three hours later, the cells were treated (+) or not (") with 50 mM trypsin for 50 min. The cells were then lysed and the rafts were isolated by sucrose-gradient ultracentrifugation. The fractions corresponding to the raft fractions (fractions 3, 4 and 5) and soluble fraction (fractions 10, 11 and 12) were pooled. Each pool was analysed by Western blot with anti-phospho-ERK (p-ERK), anti-ERK (ERK) or anti-gE antibodies or by using the cholera toxin B subunit (GM1). Fold activity of p-ERK was evaluated based on the Scion IMAGE program.
